PLK1 and cancer: In esophageal squamous cell carcinoma, downregulation of PLK1 can inhibit the pentose phosphate pathway, reduce NADPH and GSH levels, thereby promoting ferroptosis, and increasing the sensitivity of cancer cells to radiotherapy and chemotherapy (Zhao et al., 2023).